发明名称 REGULATING LIPID LEVELS VIA THE ZMAX1.
摘要 <p>The present invention relates to the high bone mass (HBM) gene, the corresponding wild-type gene (Zmax1), and mutants thereof. The genes identified in the present invention are implicated in regulation of physiological lipid levels, and thereby lipid-mediated diseases and conditions. The invention also provides nucleic acids, including coding sequences, oligonucleotide primers and probes, proteins, cloning vectors, expression vectors, transformed hosts, methods of developing pharmaceutical compositions, methods of identifying molecules involved in lipid level regulation in a subject. In preferred embodiments, the present invention is directed to methods for treating and preventing atherosclerosis, arteriosclerosis cardiovascular disease, atherosclerotic and arteriosclerotic associated conditions.</p>
申请公布号 MXPA02011588(A) 申请公布日期 2004.05.17
申请号 MX2002PA11588 申请日期 2001.05.25
申请人 GENOME THERAPEUTICS CORPORATION 发明人 CARULLI, JOHN, P.
分类号 G01N33/50;A61K31/095;A61K31/192;A61K31/22;A61K31/351;A61K31/366;A61K31/455;A61K31/565;A61K31/7088;A61K31/785;A61K38/00;A61K39/395;A61K45/00;A61K45/06;A61K48/00;A61P3/06;A61P9/10;C07K14/47;C12N15/09;C12Q1/02;G01N33/15;G01N33/53;G01N33/68;(IPC1-7):G01N33/68 主分类号 G01N33/50
代理机构 代理人
主权项
地址